Effect of use of test product on vaginal microbiota
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000049695
- Lead Sponsor
- Miura Clinic, Medical Corporation Kanonkai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 25
Not provided
(1) Subjects with a history of diabetes, liver disease, renal disease, gastrointestinal disease, heart disease, respiratory disease, peripheral vascular disease, or other serious disease (2) Subjects with diseases currently being treated (3) Subjects with a history of gynecological disease (endometriosis, uterine fibroids, ovarian cysts, cervical cancer, uterine cancer, etc.) (4) Subjects with food and drug allergies (5) Female subjects who wish to become pregnant while participating in this study, female subjects who are pregnant (including those who may be pregnant) or who are breastfeeding (6) Subjects using products or drugs that affect hormone balance (7) Subjects receiving antibiotics (8) Subjects who participate in strenuous sports and who are on a diet (9)Subjects with irregular lifestyle (10) Subjects who cannot stop taking health foods (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (11) Subjects who are continuously receiving medical treatment (including OTC and prescription drugs) (12) Subjects who consume alcohol excessively (13) Subjects who cannot abstain from alcohol from the day before the test to the day of the test (14) Subjects participating in or planning to participate in other clinical trials at the start of this study (15) Subjects who are otherwise judged by the principal investigator or subinvestigator to be unsuitable for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method vaginal microbiota
- Secondary Outcome Measures
Name Time Method